Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

indianexpress.com - Nischai Vats - Trump's Iran sanctions: Why India's rice, pharma exports are at risk
Trump's Iran sanctions: Why India's rice, pharma exports are at risk
The Indian Express

3 min read New Delhi Make us preferred source on Google The US has launched a sweeping new campaign to isolate Iran economically, warning foreign companies and countries that continue doing business with Tehran that they could face sanctions and…

newswire.ca - Groupe LSL PHARMA INC. - LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
CNW

Record quarterly revenues from both the CMO and Private Label business segments; Results include the commercial launch of the new eye-drops portfolio; Health Canada Remediation plan and production capacity scale-up at Steri-Med progressing as…

thehindu.com - The Hindu Bureau - Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
The Hindu

Generic drugmaker Natco Pharma is investing an additional $14 million in U.S.-based biotechnology company eGenesis, which is developing genetically engineered, human-compatible organs for transplantation. The latest investment will be made through…

thehindu.com - The Hindu Bureau - Dr. Reddy's CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
Dr. Reddy's CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
The Hindu

Contract research, development and manufacturing organisation Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy's Laboratories, has entered into a long-term manufacturing and supply agreement (MSA) with a leading global pharmaceutical…

straitstimes.com - How big pharma targets obesity in China's weight-loss market
How big pharma targets obesity in China's weight-loss market
The Straits Times

SHANGHAI – Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription…

thehindubusinessline.com - Natco Pharma to invest $14 million in eGenesis Inc
Natco Pharma to invest $14 million in eGenesis Inc
BusinessLine

Natco Pharma on Tuesday said it is investing $14 million (over ₹130 crore) in eGenesis Inc, a US-based biotechnology firm, through its two subsidiaries. As part of the transaction, Natco Pharma (Canada) Inc will invest $9.5 million and Natco…

marketbeat.com - Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
MarketBeat

Parkman Healthcare Partners LLC acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional…

marketbeat.com - NervGen Pharma (NASDAQ:NGEN) Given Average Recommendation of 'Moderate Buy' by Analysts
NervGen Pharma (NASDAQ:NGEN) Given Average Recommendation of 'Moderate Buy' by Analysts
MarketBeat

Shares of NervGen Pharma (NASDAQ:NGEN - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year High - Here's What Happened
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year High - Here's What Happened
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Tuesday. The company traded as high as $62.20 and last traded at $62.0140, with a volume of 631154 shares trading hands. The stock had previously closed…

marketbeat.com - The Manufacturers Life Insurance Company Purchases New Stake in BridgeBio Pharma, Inc. $BBIO
The Manufacturers Life Insurance Company Purchases New Stake in BridgeBio Pharma, Inc. $BBIO
MarketBeat

The Manufacturers Life Insurance Company acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…

swissinfo.ch - Aylin Elçi - Swiss non-profit drugmakers team up as funding shrinks
Swiss non-profit drugmakers team up as funding shrinks
www.swissinfo.ch

• Three Geneva-based non-profit drug developers are pooling resources for R&D, advocacy and communications. • Pharma R&D spending on neglected diseases fell from $824 million in 2018 to $623 million in 2024. • Experts are…

thehindubusinessline.com - CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
BusinessLine

The Central Bureau of Narcotics (CBN) under the finance ministry and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, on Monday signed an agreement to boost exports of pharma…

afaqs.com - afaqs! news bureau - WPP Media elevates Kketan Chopra to senior vice president- commerce
WPP Media elevates Kketan Chopra to senior vice president- commerce
afaqs!

Kketan Chopra has been promoted to senior vice president – WPP Commerce at WPP Media. He announced the move in a LinkedIn post. He wrote: 'I'm happy to share that I've been promoted to Senior Vice President – WPP Commerce.' Chopra has…

rediff.com - Abhishek Kumar - If Earnings Growth Returns, Capital Can Flow Back To India
If Earnings Growth Returns, Capital Can Flow Back To India
Rediff.com

'India is vulnerable to the West Asia crisis in three ways: Energy costs, the business Indian companies conduct in the region, and remittances from the Indian diaspora.' 'Sustained FII selling has hurt largecaps disproportionately because foreign…

fool.com - Motley Fool Transcribing - Evogene (EVGN) Q2 2026 Earnings Call Transcript
Evogene (EVGN) Q2 2026 Earnings Call Transcript
The Motley Fool

Tuesday, Aug. 18, 2026 at 9:00 a.m. ET Chairman of the Board of Directors - Nir Nimrodi President and CEO - Ofer Haviv VP Finance - Polina Ravzin Cash and Cash Equivalents -- $9.3 million as of June 30, 2026, reflecting the company's current…

Receive a Daily briefing on Pharma Industry News

Get Started